Literature DB >> 29964296

Astrocytes in juvenile neuronal ceroid lipofuscinosis (CLN3) display metabolic and calcium signaling abnormalities.

Megan E Bosch1, Tammy Kielian2.   

Abstract

Juvenile neuronal ceroid lipofuscinosis (JNCL) is a lysosomal storage disease caused by autosomal recessive mutations in ceroid lipofuscinosis 3 (CLN3). Children with JNCL experience progressive visual, cognitive, and motor deterioration with a decreased life expectancy (late teens-early 20s). Neuronal loss is thought to occur, in part, via glutamate excitotoxicity; however, little is known about astrocyte glutamate regulation in JNCL. Spontaneous Ca2+ oscillations were reduced in murine Cln3Δex7/8 astrocytes, which were also observed following glutamate or cytokine exposure. Astrocyte glutamate transport is an energy-demanding process and disruptions in metabolic pathways could influence glutamate homeostasis in Cln3Δex7/8 astrocytes. Indeed, basal mitochondrial respiration and ATP production were significantly reduced in Cln3Δex7/8 astrocytes. These changes were not attributable to reduced mitochondria, since mitochondrial DNA levels were similar between wild type and Cln3Δex7/8 astrocytes. Interestingly, despite these functional deficits in Cln3Δex7/8 astrocytes, glutamate transporter expression and glutamate uptake were not dramatically affected. Concurrent with impaired astrocyte metabolism and Ca2+ signaling, murine Cln3Δex7/8 neurons were hyper-responsive to glutamate, as reflected by heightened and prolonged Ca2+ signals. These findings identify intrinsic metabolic and Ca2+ signaling defects in Cln3Δex7/8 astrocytes that may contribute to neuronal dysfunction in CLN3 disease. This article is part of the Special Issue "Lysosomal Storage Disorders".
© 2018 International Society for Neurochemistry.

Entities:  

Keywords:  Astrocyte; CLN3; calcium signaling; mitochondrial dysfunction

Mesh:

Substances:

Year:  2018        PMID: 29964296      PMCID: PMC7233413          DOI: 10.1111/jnc.14545

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  82 in total

1.  Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy.

Authors:  W S van der Hel; R G E Notenboom; I W M Bos; P C van Rijen; C W M van Veelen; P N E de Graan
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

2.  Standardized assessment of seizures in patients with juvenile neuronal ceroid lipofuscinosis.

Authors:  Erika F Augustine; Heather R Adams; Christopher A Beck; Amy Vierhile; Jennifer Kwon; Paul G Rothberg; Frederick Marshall; Robert Block; James Dolan; Jonathan W Mink
Journal:  Dev Med Child Neurol       Date:  2014-11-11       Impact factor: 5.449

Review 3.  Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.

Authors:  Keetae Kim; Seok-Geun Lee; Timothy P Kegelman; Zhao-Zhong Su; Swadesh K Das; Rupesh Dash; Santanu Dasgupta; Paola M Barral; Michael Hedvat; Paul Diaz; John C Reed; John L Stebbins; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2011-10       Impact factor: 6.384

4.  Distinct early molecular responses to mutations causing vLINCL and JNCL presage ATP synthase subunit C accumulation in cerebellar cells.

Authors:  Yi Cao; John F Staropoli; Sunita Biswas; Janice A Espinola; Marcy E MacDonald; Jong-Min Lee; Susan L Cotman
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

5.  High-resolution magic angle spinning and 1H magnetic resonance spectroscopy reveal significantly altered neuronal metabolite profiles in CLN1 but not in CLN3.

Authors:  Beathe Sitter; Taina Autti; Jaana Tyynelä; Ursula Sonnewald; Tone F Bathen; Johanna Puranen; Pirkko Santavuori; Matti J Haltia; Anders Paetau; Tuomo Polvikoski; Ingrid S Gribbestad; Anna-Maija Häkkinen
Journal:  J Neurosci Res       Date:  2004-09-01       Impact factor: 4.164

6.  Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke.

Authors:  Jason Liauw; Stanley Hoang; Michael Choi; Cagla Eroglu; Matthew Choi; Guo-hua Sun; Matthew Percy; Benjamin Wildman-Tobriner; Tonya Bliss; Raphael G Guzman; Ben A Barres; Gary K Steinberg
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-02       Impact factor: 6.200

7.  Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype.

Authors:  Juan Xiong; Tammy Kielian
Journal:  J Neurochem       Date:  2013-08-22       Impact factor: 5.372

8.  Glutamate-mediated astrocyte-neuron signalling.

Authors:  V Parpura; T A Basarsky; F Liu; K Jeftinija; S Jeftinija; P G Haydon
Journal:  Nature       Date:  1994-06-30       Impact factor: 49.962

9.  Multifunctional role of astrocytes as gatekeepers of neuronal energy supply.

Authors:  Jillian L Stobart; Christopher M Anderson
Journal:  Front Cell Neurosci       Date:  2013-04-10       Impact factor: 5.505

10.  L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the 'collusion' hypothesis for increased extracellular L-glutamate concentration in neuroinflammation.

Authors:  Junpei Takaki; Koki Fujimori; Marie Miura; Takeshi Suzuki; Yuko Sekino; Kaoru Sato
Journal:  J Neuroinflammation       Date:  2012-12-23       Impact factor: 8.322

View more
  9 in total

1.  Ppt1-deficiency dysregulates lysosomal Ca++ homeostasis contributing to pathogenesis in a mouse model of CLN1 disease.

Authors:  Avisek Mondal; Abhilash P Appu; Tamal Sadhukhan; Maria B Bagh; Rafael M Previde; Sriparna Sadhukhan; Stanko Stojilkovic; Aiyi Liu; Anil B Mukherjee
Journal:  J Inherit Metab Dis       Date:  2022-03-17       Impact factor: 4.750

2.  Neuronal genetic rescue normalizes brain network dynamics in a lysosomal storage disorder despite persistent storage accumulation.

Authors:  Rebecca C Ahrens-Nicklas; Luis Tecedor; Arron F Hall; Owen Kane; Richard J Chung; Elena Lysenko; Eric D Marsh; Colleen S Stein; Beverly L Davidson
Journal:  Mol Ther       Date:  2022-04-05       Impact factor: 12.910

3.  Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.

Authors:  Yu Zhong; Kabhilan Mohan; Jinpeng Liu; Ahmad Al-Attar; Penghui Lin; Robert M Flight; Qiushi Sun; Marc O Warmoes; Rahul R Deshpande; Huijuan Liu; Kyung Sik Jung; Mihail I Mitov; Nianwei Lin; D Allan Butterfield; Shuyan Lu; Jinze Liu; Hunter N B Moseley; Teresa W M Fan; Mark E Kleinman; Qing Jun Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-06-25       Impact factor: 6.633

Review 4.  Recent Insights into NCL Protein Function Using the Model Organism Dictyostelium discoideum.

Authors:  Meagan D McLaren; Sabateeshan Mathavarajah; Robert J Huber
Journal:  Cells       Date:  2019-02-02       Impact factor: 7.666

Review 5.  Cellular models of Batten disease.

Authors:  Christopher J Minnis; Christopher D Thornton; Lorna M FitzPatrick; Tristan R McKay
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-10-23       Impact factor: 5.187

6.  Neuronal Ceroid Lipofuscinoses: Connecting Calcium Signalling through Calmodulin.

Authors:  Sabateeshan Mathavarajah; Danton H O'Day; Robert J Huber
Journal:  Cells       Date:  2018-10-29       Impact factor: 6.600

7.  Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis.

Authors:  Gemma Gomez-Giro; Jonathan Arias-Fuenzalida; Javier Jarazo; Dagmar Zeuschner; Muhammad Ali; Nina Possemis; Silvia Bolognin; Rashi Halder; Christian Jäger; Willemijn F E Kuper; Peter M van Hasselt; Holm Zaehres; Antonio Del Sol; Herman van der Putten; Hans R Schöler; Jens C Schwamborn
Journal:  Acta Neuropathol Commun       Date:  2019-12-30       Impact factor: 7.801

8.  Exogenous Flupirtine as Potential Treatment for CLN3 Disease.

Authors:  Katia Maalouf; Joelle Makoukji; Sara Saab; Nadine J Makhoul; Angelica V Carmona; Nihar Kinarivala; Noël Ghanem; Paul C Trippier; Rose-Mary Boustany
Journal:  Cells       Date:  2020-08-11       Impact factor: 6.600

9.  CLN3, at the crossroads of endocytic trafficking.

Authors:  Susan L Cotman; Stéphane Lefrancois
Journal:  Neurosci Lett       Date:  2021-07-16       Impact factor: 3.197

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.